Meta, Snowflake, PayPal And Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Malcolm Ethridge of CIC Wealth Management named PayPal Holdings, Inc. (NASDAQ:PYPL) his final trade.

On Feb. 25, PayPal issued an outlook ahead of its Investor Day event. The company reiterated guidance for an adjusted EPS growth of 6%-10% and transaction margin dollar growth, excluding the impact of interest on customer balances of growth of at least 5%. The company expects high single-digit transaction margin dollar growth and low teens+ adjusted EPS growth by 2027.

Kevin Simpson of Capital Wealth Planning said Meta Platforms, Inc. (NASDAQ:META) is his top pick out of the Mag 7 names, having great free cash flow and huge margins.

On Friday, Citizens Capital Markets analyst Andrew Boone reiterated Meta Platforms with a Market Outperform rating and maintained a $750 price target.

Don't forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:ABBV) is a stock in a nice uptrend. It has pulled back a little bit. It has a very attractive valuation, good management and good product pipelines, he added.

AbbVie released on March 15 the final analysis of the confirmatory Phase 3 MIRASOL trial of Elahere (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy.

Stephanie Link picked Snowflake Inc. (NYSE:SNOW), down 23% from its highs.

As per the recent news, Snowflake, on March 6, appointed Mike Gannon as chief revenue officer.

Price Action:

• PayPal shares dipped 5.4% to close at $65.15 on Friday.
• Meta shares fell 4.3% to close at $576.74 during Friday's session.
• AbbVie shares gained 1.3% to close at $205.29 on Friday.
• Snowflake shares dipped 4.1% to settle at $150.63.

Check This Out:

• Jim Cramer: Healthpeak Properties Is A ‘Reasonable’ REIT, Recommends Buying This Health Care Stock

Photo: Shutterstock